Two current projects, which are a cost-sharing effort between 12 members of RegenMed Development Organization and the Medical Technology Enterprise Consortium, aim to advance platform technologies that address regenerative medicine manufacturing challenges.
Universal Bioink
One project is developing a universal bioink with tunable mechanical properties for additive manufacturing (3D bioprinting) of implantable regenerative medicine clinical products.
Universal Cell Media
Another project is developing a universal cell media that will be a GMP-grade-defined formulation that can help accelerate cell therapy and tissue engineering manufacturing product development.
